Ian Rhodes
About Ian Rhodes
Ian Rhodes is the Interim Chief Financial Officer of Q/C Technologies, Inc. (QCLS) and has served in this role since February 1, 2021; he is a licensed CPA with a B.S. in Business Administration (Accounting) from Seton Hall University and began his career with 15 years at PricewaterhouseCoopers . He has also served as CFO of Renatus Tactical Acquisition Corp I since August 2024, reflecting ongoing external finance leadership alongside his QCLS role . Age 51 as of 2025, Rhodes operates under a consulting arrangement rather than a traditional employment contract, with compensation paid via Brio Financial Group, aligning costs to company needs during capital restructuring and financing activity .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| PricewaterhouseCoopers | Various roles | ~15 years | Foundation in audit/finance; core accounting expertise |
| Calmare Therapeutics | CFO | 2014–2016 | Finance leadership in medtech |
| GlyEco, Inc. | CFO; later President/CEO and Director | 2016–2018 | Transition to CEO; operational and strategic leadership |
| Greyston Bakery & Foundation | Interim CFO | 2018–2019 | Interim finance leadership in mission-driven enterprise |
| Roadway Moving and Storage | Interim CFO | 2020 | Operational finance in logistics |
| Brio Financial Group | Consultant | 2021–present | Provides outsourced CFO services to QCLS under consulting agreement |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Renatus Tactical Acquisition Corp I | Chief Financial Officer | Aug 2024–present | Parallel CFO role at SPAC |
| Brio Financial Group | Senior finance consultant | 2021–present | Vehicle for QCLS CFO consulting arrangement |
Fixed Compensation
| Component | Terms | Amount | Notes |
|---|---|---|---|
| Consulting retainer (Brio) | Initial retainer fee | $7,500 | One-time retainer upon engagement |
| Monthly consulting fee (Brio) | Fixed monthly payment | $13,500 | Ongoing fee; implied annualized $162,000 if unchanged |
| Expenses | Travel and out-of-pocket costs | Reimbursed | As incurred per agreement |
| Contract status | Consulting agreement dated July 21, 2020; expired June 30, 2021; continued on same terms | Ongoing | Rhodes continues under same terms post-expiration |
The company profile similarly lists CFO compensation at $162k, consistent with the implied annualization of the monthly consulting fee .
Note: Rhodes is paid via consulting arrangement; no base salary or target bonus percentages are disclosed in filings .
Performance Compensation
- No individual bonus targets, performance metrics, or payouts are disclosed for Ian Rhodes in QCLS filings .
- The company’s 2021 Equity Incentive Plan permits performance-based awards tied to criteria including revenues, EBITDA, EPS, stock price/TSR, ROE/ROA, market share, and strategic milestones; however, no specific grants or weightings for Rhodes are disclosed .
Equity Ownership & Alignment
| Metric (Record Date: Sep 18, 2025) | Ian Rhodes | Notes |
|---|---|---|
| Common shares beneficially owned | 0 | Rhodes is not listed with beneficial ownership in the NEO table |
| % of common shares outstanding | 0.00% | 2,052,974 common shares outstanding at record date |
| Preferred (Series D/G/H/I) held | 0 | No preferred holdings disclosed for Rhodes |
| RSUs/options (vested/unvested) | Not disclosed | No awards listed for Rhodes in ownership table |
| Shares pledged as collateral | None disclosed | No pledging reported |
| Ownership guidelines | Not disclosed | No executive ownership guidelines disclosed for Rhodes |
Plan includes clawback/recoupment provisions for awards in event of financial restatement per company policy .
Employment Terms
- Appointment and term: Rhodes appointed Interim CFO effective January 29, 2021; service provided through Brio under consulting terms continuing post-expiration of the initial agreement .
- Compensation structure: Consulting retainer and fixed monthly fee with expense reimbursement; no severance, change-of-control protections, or auto-renewal clauses disclosed for Rhodes’ arrangement .
- Non-compete/non-solicit: Not disclosed in filings; arrangement characterized as consulting rather than employment .
- Equity plan context: Share pool increased to 1,400,000 under the Incentive Plan Amendment approved Nov 14, 2025, enabling future equity grants; no specific grant to Rhodes disclosed .
Compensation Structure Analysis
- At-risk vs fixed pay: Rhodes’ compensation is fixed-fee consulting without disclosed variable bonus or PSU targets, indicating limited direct pay-for-performance linkage at the individual level .
- Equity participation: No disclosed equity holdings or awards for Rhodes as of the record date; plan enlargement suggests capacity for future awards but none are specified for Rhodes .
- Governance guardrails: The Plan prohibits option/SAR repricing without shareholder approval and allows performance-conditioned awards, aligning potential future grants with shareholder interests .
Vesting Schedules and Insider Selling Pressure
- Insider transactions: No Form 4 data retrieved for Rhodes in the 2023–2025 period due to data access limitations; no selling pressure indicated from ownership as he held no disclosed shares at record date .
- Vesting: No specific RSU/option grants or vesting schedules are disclosed for Rhodes in company filings .
Related Party Transactions and Risk Indicators
- Related parties: No related party transactions involving Rhodes disclosed in available documents –.
- Dilution context: Significant capital structure changes (Series H/I preferred, warrants, milestone securities) and reverse split mechanics may affect overall equity incentives and market dynamics; not specific to Rhodes but relevant to compensation alignment via equity – – .
Say-on-Pay & Compensation Committee
- Say-on-Pay: Not disclosed for 2025 special meeting; the agenda focused on issuance approval, plan amendment, reverse split, and adjournment – –.
- Committee: The Equity Plan is administered by the compensation committee or designated committee; specific membership details not disclosed in the special meeting proxy .
Investment Implications
- Low skin-in-the-game: With no disclosed personal share ownership or equity awards, Rhodes has limited direct alignment via share price, reducing insider-selling risk but also reducing performance-linked upside .
- Cost-flexibility and retention: Consulting-based CFO compensation (~$162k implied annually via fixed monthly fee) offers cost flexibility but may entail higher retention risk relative to full-time, equity-linked packages; no severance or change-of-control protections disclosed .
- Prospective equity incentives: The approved expansion of the equity plan to 1.4 million shares increases optionality for future performance-based grants that could strengthen alignment if awarded; monitor post-approval grants and any RSU/PSU allocations to Rhodes .
- Capital structure volatility: Ongoing preferred conversions, warrants, and potential milestone securities issuance can drive dilution and volatility; these dynamics may overshadow executive incentive signals until capital stabilization occurs – .